Literature DB >> 29492607

Intrahepatic cholangiocarcinoma: can imaging phenotypes predict survival and tumor genetics?

Emily A Aherne1, Linda M Pak2, Debra A Goldman3, Mithat Gonen3, William R Jarnagin2, Amber L Simpson2, Richard K Do4.   

Abstract

PURPOSE: On computed tomography (CT), intrahepatic cholangiocarcinomas (ICC) are a visibly heterogeneous group of tumors. The purpose of this study was to investigate the associations between CT imaging phenotypes, patient survival, and known genetic markers.
METHODS: A retrospective study was performed with 66 patients with surgically resected ICC. Pre-surgical CT images of ICC were assessed by radiologists blinded to tumor genetics and patient clinical data. Associations between qualitative imaging features and overall survival (OS) and disease-free survival (DFS) were performed with Cox proportional hazards regression and visualized with Kaplan-Meier plots. Associations between radiographic features and genetic pathways (IDH1, Chromatin and RAS-MAPK) were assessed with Fisher's Exact test and the Wilcoxon Rank sum test where appropriate and corrected for multiple comparisons within each pathway using the False Discovery Rate correction.
RESULTS: Three imaging features were significantly associated with a higher risk of death: necrosis (hazard ratio (HR) 2.95 95% CI 1.44-6.04, p = 0.029), satellite nodules (HR 3.29, 95% CI:1.35-8.02, p = 0.029), and vascular encasement (HR 2.63, 95% CI 1.28-5.41, p = 0.029). Additionally, with each increase in axial size, the risk of death increased (HR 1.14, 95% CI 1.03-1.26, p = 0.029). Similar to findings for OS, satellite nodules (HR 3.81, 95% CI 1.88-7.71, p = 0.002) and vascular encasement (HR 2.25, 95% CI 1.24-4.06, p = 0.019) were associated with increased risk of recurrence/death. No significant associations were found between radiographic features and genes in the IDH1, Chromatin or RAS-MAPK pathways (p = 0.63-84).
CONCLUSION: This preliminary analysis of resected ICC suggests associations between CT imaging features and OS and DFS. No association was identified between imaging features and currently known genetic pathways.

Entities:  

Keywords:  Cholangiocarcinoma; Radiogenomics; Radiomics; Survival

Year:  2018        PMID: 29492607      PMCID: PMC6113129          DOI: 10.1007/s00261-018-1505-4

Source DB:  PubMed          Journal:  Abdom Radiol (NY)


  38 in total

1.  Genomic spectra of biliary tract cancer.

Authors:  Hiromi Nakamura; Yasuhito Arai; Yasushi Totoki; Tomoki Shirota; Asmaa Elzawahry; Mamoru Kato; Natsuko Hama; Fumie Hosoda; Tomoko Urushidate; Shoko Ohashi; Nobuyoshi Hiraoka; Hidenori Ojima; Kazuaki Shimada; Takuji Okusaka; Tomoo Kosuge; Shinichi Miyagawa; Tatsuhiro Shibata
Journal:  Nat Genet       Date:  2015-08-10       Impact factor: 38.330

2.  Correlation of CT patterns of primary intrahepatic cholangiocarcinoma at the time of presentation with the metastatic spread and clinical outcomes: retrospective study of 92 patients.

Authors:  Akshay D Baheti; Sree Harsha Tirumani; Atul B Shinagare; Michael H Rosenthal; Jason L Hornick; Nikhil H Ramaiya; Brian M Wolpin
Journal:  Abdom Imaging       Date:  2014-12

3.  Integrative molecular analysis of intrahepatic cholangiocarcinoma reveals 2 classes that have different outcomes.

Authors:  Daniela Sia; Yujin Hoshida; Augusto Villanueva; Sasan Roayaie; Joana Ferrer; Barbara Tabak; Judit Peix; Manel Sole; Victoria Tovar; Clara Alsinet; Helena Cornella; Brandy Klotzle; Jian-Bing Fan; Christian Cotsoglou; Swan N Thung; Josep Fuster; Samuel Waxman; Juan Carlos Garcia-Valdecasas; Jordi Bruix; Myron E Schwartz; Rameen Beroukhim; Vincenzo Mazzaferro; Josep M Llovet
Journal:  Gastroenterology       Date:  2013-01-04       Impact factor: 22.682

Review 4.  Intrahepatic cholangiocarcinoma: macroscopic type and stage classification.

Authors:  Susumu Yamasaki
Journal:  J Hepatobiliary Pancreat Surg       Date:  2003

5.  Natural History and Prognostic Factors of Advanced Cholangiocarcinoma without Surgery, Chemotherapy, or Radiotherapy: A Large-Scale Observational Study.

Authors:  Jongha Park; Myung-Hwan Kim; Kyu-Pyo Kim; Do Hyun Park; Sung-Hoon Moon; Tae Jun Song; Junbum Eum; Sang Soo Lee; Dong Wan Seo; Sung Koo Lee
Journal:  Gut Liver       Date:  2009-12-31       Impact factor: 4.519

6.  Identification of noninvasive imaging surrogates for brain tumor gene-expression modules.

Authors:  Maximilian Diehn; Christine Nardini; David S Wang; Susan McGovern; Mahesh Jayaraman; Yu Liang; Kenneth Aldape; Soonmee Cha; Michael D Kuo
Journal:  Proc Natl Acad Sci U S A       Date:  2008-03-24       Impact factor: 11.205

7.  The frequency of KRAS and BRAF mutations in intrahepatic cholangiocarcinomas and their correlation with clinical outcome.

Authors:  Scott Robertson; Omar Hyder; Rebecca Dodson; Suresh K Nayar; Justin Poling; Katie Beierl; James R Eshleman; Ming-Tseh Lin; Timothy M Pawlik; Robert A Anders
Journal:  Hum Pathol       Date:  2013-10-15       Impact factor: 3.466

8.  Exome sequencing identifies frequent inactivating mutations in BAP1, ARID1A and PBRM1 in intrahepatic cholangiocarcinomas.

Authors:  Yuchen Jiao; Timothy M Pawlik; Robert A Anders; Florin M Selaru; Mirte M Streppel; Donald J Lucas; Noushin Niknafs; Violeta Beleva Guthrie; Anirban Maitra; Pedram Argani; G Johan A Offerhaus; Juan Carlos Roa; Lewis R Roberts; Gregory J Gores; Irinel Popescu; Sorin T Alexandrescu; Simona Dima; Matteo Fassan; Michele Simbolo; Andrea Mafficini; Paola Capelli; Rita T Lawlor; Andrea Ruzzenente; Alfredo Guglielmi; Giampaolo Tortora; Filippo de Braud; Aldo Scarpa; William Jarnagin; David Klimstra; Rachel Karchin; Victor E Velculescu; Ralph H Hruban; Bert Vogelstein; Kenneth W Kinzler; Nickolas Papadopoulos; Laura D Wood
Journal:  Nat Genet       Date:  2013-11-03       Impact factor: 38.330

9.  Radiogenomic mapping of edema/cellular invasion MRI-phenotypes in glioblastoma multiforme.

Authors:  Pascal O Zinn; Bhanu Mahajan; Bhanu Majadan; Pratheesh Sathyan; Sanjay K Singh; Sadhan Majumder; Ferenc A Jolesz; Rivka R Colen
Journal:  PLoS One       Date:  2011-10-05       Impact factor: 3.240

10.  Radiomics: Images Are More than Pictures, They Are Data.

Authors:  Robert J Gillies; Paul E Kinahan; Hedvig Hricak
Journal:  Radiology       Date:  2015-11-18       Impact factor: 11.105

View more
  8 in total

Review 1.  Problematic lesions in cirrhotic liver mimicking hepatocellular carcinoma.

Authors:  Myeong-Jin Kim; Sunyoung Lee; Chansik An
Journal:  Eur Radiol       Date:  2019-02-20       Impact factor: 5.315

2.  Machine learning radiomics can predict early liver recurrence after resection of intrahepatic cholangiocarcinoma.

Authors:  Joshua S Jolissaint; Tiegong Wang; Kevin C Soares; Joanne F Chou; Mithat Gönen; Linda M Pak; Thomas Boerner; Richard K G Do; Vinod P Balachandran; Michael I D'Angelica; Jeffrey A Drebin; T P Kingham; Alice C Wei; William R Jarnagin; Jayasree Chakraborty
Journal:  HPB (Oxford)       Date:  2022-02-17       Impact factor: 3.842

3.  Genomic profiling of multifocal intrahepatic cholangiocarcinoma reveals intraindividual concordance of genetic alterations.

Authors:  Sung Hwan Lee; Eve B Simoneau; Tatiana Karpinets; P Andrew Futreal; Jianjun Zhang; Milind Javle; Jianhua Zhang; Jean-Nicolas Vauthey; Ju-Seog Lee; Jeannelyn S Estrella; Yun Shin Chun
Journal:  Carcinogenesis       Date:  2021-04-17       Impact factor: 4.944

4.  Outcomes assessment in intrahepatic cholangiocarcinoma using qualitative and quantitative imaging features.

Authors:  Michael J King; Stefanie Hectors; Karen M Lee; Olamide Omidele; James S Babb; Myron Schwartz; Parissa Tabrizian; Bachir Taouli; Sara Lewis
Journal:  Cancer Imaging       Date:  2020-07-03       Impact factor: 3.909

Review 5.  Combining molecular and imaging metrics in cancer: radiogenomics.

Authors:  Roberto Lo Gullo; Isaac Daimiel; Elizabeth A Morris; Katja Pinker
Journal:  Insights Imaging       Date:  2020-01-03

6.  An update on radiomics techniques in primary liver cancers.

Authors:  Vincenza Granata; Roberta Fusco; Sergio Venazio Setola; Igino Simonetti; Diletta Cozzi; Giulia Grazzini; Francesca Grassi; Andrea Belli; Vittorio Miele; Francesco Izzo; Antonella Petrillo
Journal:  Infect Agent Cancer       Date:  2022-03-04       Impact factor: 2.965

Review 7.  Radiomics and radiogenomics of primary liver cancers.

Authors:  Woo Kyoung Jeong; Neema Jamshidi; Ely Richard Felker; Steven Satish Raman; David Shinkuo Lu
Journal:  Clin Mol Hepatol       Date:  2018-11-16

8.  Integrated prognostication of intrahepatic cholangiocarcinoma by contrast-enhanced computed tomography: the adjunct yield of radiomics.

Authors:  Mario Silva; Michele Maddalo; Eleonora Leoni; Sara Giuliotti; Gianluca Milanese; Caterina Ghetti; Elisabetta Biasini; Massimo De Filippo; Gabriele Missale; Nicola Sverzellati
Journal:  Abdom Radiol (NY)       Date:  2021-06-24
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.